Cargando…
Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
BACKGROUND: Medications such as buprenorphine are considered the gold standard for the treatment of opioid use disorders. This study aimed to determine whether less restrictive buprenorphine prescribing practices during the COVID-19 pandemic impacted retention in and adherence to buprenorphine among...
Autores principales: | Ward, Kathleen M., Scheim, Ayden, Wang, Jonathan, Cocchiaro, Benjamin, Singley, Katie, Roth, Alexis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040407/ https://www.ncbi.nlm.nih.gov/pubmed/35497489 http://dx.doi.org/10.1016/j.dadr.2022.100055 |
Ejemplares similares
-
Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic
por: Bowles, Jeanette M., et al.
Publicado: (2023) -
Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability
por: Brooner, Robert K., et al.
Publicado: (2022) -
Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
por: Roy, Payel Jhoom, et al.
Publicado: (2023) -
Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023) -
The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)